Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of juvenile idiopathic arthritis: a revolution in care
Matthew L. Stoll, Randy Q. Cron
Pediatric Rheumatology (2014) Vol. 12, Iss. 1
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Paul La Rosée, AnnaCarin Horne, Melissa Hines, et al.
Blood (2019) Vol. 133, Iss. 23, pp. 2465-2477
Open Access | Times Cited: 831
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
Jurgen Sota, Antonella Insalaco, Rolando Cimaz, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 614
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne, Sabrin Albeituni, Kim E. Nichols, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 560
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
Lina Zaripova, Angela Midgley, Stephen E. Christmas, et al.
Pediatric Rheumatology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 192
Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors
Grant S. Schulert, Shima Yasin, Brenna Carey, et al.
Arthritis & Rheumatology (2019) Vol. 71, Iss. 11, pp. 1943-1954
Open Access | Times Cited: 171
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
Alessandro Consolaro, Gabriella Giancane, Alessandra Alongi, et al.
The Lancet Child & Adolescent Health (2019) Vol. 3, Iss. 4, pp. 255-263
Open Access | Times Cited: 159
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Melissa Hines, Tristan Knight, Kevin O. McNerney, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 7, pp. 438.e1-438.e16
Open Access | Times Cited: 141
Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society
Stephan Ehl, Itziar Astigarraga, Tatiana von Bahr Greenwood, et al.
The Journal of Allergy and Clinical Immunology In Practice (2018) Vol. 6, Iss. 5, pp. 1508-1517
Closed Access | Times Cited: 157
Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients
V. Calvo-Río, M. Santos-Gόmez, Inmaculada Calvo, et al.
Arthritis & Rheumatology (2016) Vol. 69, Iss. 3, pp. 668-675
Open Access | Times Cited: 145
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis
Grant S. Schulert, Francesca Minoia, John F. Bohnsack, et al.
Arthritis Care & Research (2017) Vol. 70, Iss. 3, pp. 409-419
Open Access | Times Cited: 122
Management of juvenile idiopathic arthritis: hitting the target
Claas Hinze, Faekah Gohar, Dirk Foell
Nature Reviews Rheumatology (2015) Vol. 11, Iss. 5, pp. 290-300
Closed Access | Times Cited: 111
Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?
Matthew L. Stoll, Chung How Kau, Peter D. Waite, et al.
Pediatric Rheumatology (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 94
Treatment of non-systemic juvenile idiopathic arthritis
Susan Shenoi, Gerd Horneff, Amita Aggarwal, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 3, pp. 170-181
Closed Access | Times Cited: 8
Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology
Eduardo Mysler, Carlos Pineda, Takahiko Horiuchi, et al.
Rheumatology International (2016) Vol. 36, Iss. 5, pp. 613-625
Open Access | Times Cited: 68
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial
Petra Müller, D. M. C. Brinkman, Dieneke Schonenberg‐Meinema, et al.
Annals of the Rheumatic Diseases (2018) Vol. 78, Iss. 1, pp. 51-59
Closed Access | Times Cited: 66
Juvenile Idiopathic Arthritis
Courtney B. Crayne, Timothy Beukelman
Pediatric Clinics of North America (2018) Vol. 65, Iss. 4, pp. 657-674
Closed Access | Times Cited: 62
A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management
Nancy Bansal, Chirag Pasricha, Pratima Kumari, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 7, pp. 103337-103337
Closed Access | Times Cited: 22
Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg
Courtney B. Crayne, Randy Q. Cron
European Journal of Rheumatology (2019) Vol. 7, Iss. -1, pp. 13-20
Open Access | Times Cited: 54
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
Cole Spencer, Kelly Rouster‐Stevens, Harry L. Gewanter, et al.
Pediatric Rheumatology (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review
Rebecca Davies, Danielle Gaynor, Kimme L Hyrich, et al.
Seminars in Arthritis and Rheumatism (2016) Vol. 46, Iss. 5, pp. 584-593
Closed Access | Times Cited: 45
Treatment in juvenile rheumatoid arthritis and new treatment options
Özgür Kasapçopur, Kenan Barut
Türk Pediatri Arşivi (2015) Vol. 50, Iss. 1, pp. 1-10
Open Access | Times Cited: 41
Advancements and progress in juvenile idiopathic arthritis: A Review of pathophysiology and treatment
Helen Huang, Wireko Andrew Awuah, Goshen David Miteu, et al.
Medicine (2024) Vol. 103, Iss. 13, pp. e37567-e37567
Open Access | Times Cited: 4
Assessment of choroidal vascularity index in juvenile idiopathic arthritis: implications for disease monitoring
İ̇brahim Edhem Yılmaz, Gizem Gürbostan Soysal, Veysel Doğru, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2025)
Open Access
Diagnostic value of synovial calprotectin (S100A8/A9) in differential diagnosis of juvenile idiopathic arthritis and pigmented villonodular synovitis in children: preliminary results of a single-center study
Aleksei N. Kozhevnikov, Elena A. Derkach, Aleksandra A. Porohova, et al.
Pediatric Traumatology Orthopaedics and Reconstructive Surgery (2025) Vol. 13, Iss. 1, pp. 5-13
Open Access
Contemporary management of TMJ involvement in JIA patients and its orofacial consequences
Priit Niibo, Chris Pruunsild, Ülle Voog‐Oras, et al.
The EPMA Journal (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top